Date of Presentation
5-2-2019 12:00 AM
College
School of Osteopathic Medicine
Poster Abstract
Pancreatic neuroendocrine tumors (PNET) are very rare and represent about 1–2% of all pancreatic tumors. Non-functional PNET (NF-PNET) is incidentally discovered in most cases. Most NF-PNETs are found at an advanced stage because patients are mostly asymptomatic. We present a case of 32-yr-old female who initially presented with increasing abdominal girth, decreased mobility, and lower extremity swelling up to the hip and was found to have an advanced NF-PNET with metastatic disease to the pelvis and liver. There have been few studies directed toward early detection and management; Computed tomography (CT) is the imaging modality of choice as well as the use of several screening biomarkers. Surgical treatment is preferred, but this option is not available for advanced disease leaving only palliative chemotherapy and radiation.
Keywords
Pancreatic neuroendocrine tumors, PNET
Disciplines
Endocrine System Diseases | Endocrinology, Diabetes, and Metabolism | Medicine and Health Sciences | Neoplasms | Oncology
Document Type
Poster
Included in
Endocrine System Diseases Commons, Endocrinology, Diabetes, and Metabolism Commons, Neoplasms Commons, Oncology Commons
A Rare Case of a Non- Functioning Pancreatic Neuroendocrine Tumor
Pancreatic neuroendocrine tumors (PNET) are very rare and represent about 1–2% of all pancreatic tumors. Non-functional PNET (NF-PNET) is incidentally discovered in most cases. Most NF-PNETs are found at an advanced stage because patients are mostly asymptomatic. We present a case of 32-yr-old female who initially presented with increasing abdominal girth, decreased mobility, and lower extremity swelling up to the hip and was found to have an advanced NF-PNET with metastatic disease to the pelvis and liver. There have been few studies directed toward early detection and management; Computed tomography (CT) is the imaging modality of choice as well as the use of several screening biomarkers. Surgical treatment is preferred, but this option is not available for advanced disease leaving only palliative chemotherapy and radiation.